PUBLIC COMPANY
saveRNA Therapeutics Inc
updated 4mo ago
community read0 votes
🐶 often sniffed alongside
top 1pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- China biotech RiboX reveals first data of circular RNA therapies in peopleBiotech investors and pharma companies have poured billions into three Boston-region startups competing to develop a next-generation version of mRNA technology that could make for more durable and…endpoints · 6d ago
- Lilly partners with Hong Kong's Metis in $1.1B deal to bolster AI nanoparticle discoveryThe collaboration is another in a series of partnerships Lilly has accumulated in both drug delivery and AI-based technologies.fiercebiotech · 8d ago
- How Abogen went from COVID hype to a $7.8B Novartis dealAfter Abogen Biosciences’ COVID shot missed the commercial window, the big question was whether its mRNA technology could create value beyond vaccines. Novartis’ $575 million upfront commitment is…biospace · 18d ago
- Novartis shareholder calls for board overhaul following costly deal setbacks: ReutersNovartis’ recent dual clinical setbacks have prompted questions from a major shareholder about the board’s oversight of dealmaking.fiercebiotech · 1mo ago
- STAT+: ARPA-H funds biotechs working on custom RNA therapiesRoche licenses a tri-specific antibody, new Trump deals may undercut its own goals, and other biotech newsstat · 1mo ago
- ARPA-H awards $125M for manufacturing custom RNA therapies on demandThe dream of making personalized genetic medicines at a moment’s notice just got a major infusion of funding from the federal government. Five groups were collectively awarded up to $125 million ...endpoints · 1mo ago
- From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotechWhether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's biopharma industry.fiercebiotech · 3mo ago
- Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 10mo ago
comments(0)
5-min edit window · permanent after that